LNAI Earnings & Financial Statements
Lunai Bioworks Inc.
$1.13
-$0.01(-0.88%)
29
Overall
--
Value
27
Tech
31
Quality
Market Cap
$5.17M
Volume
23.38K
52W Range
$1.21 - $13.28
Target Price
--
LNAI earnings and financial statements: Lunai Bioworks Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
LNAI Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | $352.7K | $3.0K | - |
| Cost of revenue | - | - | - | - | $13.80M |
| Operating income | -$18.55M | -$81.64M | -$38.56M | -$116.08M | -$23.40M |
| EBITDA | -$177.15M | -$87.29M | -$38.86M | -$112.94M | -$26.35M |
| Net income | -$178.01M | -$88.43M | -$39.68M | -$113.43M | -$26.72M |
| EPS (diluted) | $-1.08 | $-67.20 | $-56.80 | - | $-45.60 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $8.23M | $163.13M | $58.30M | $84.63M | $189.61M |
| Total liabilities | $29.58M | $31.15M | $11.80M | $12.01M | $14.94M |
| Shareholders’ equity | -$21.35M | $131.98M | $46.50M | $72.62M | $174.66M |
| Cash and equivalents | $92.7K | $220.5K | $1.87M | $9.17M | $20.66M |
| Long-term debt | $424.5K | $1.09M | $775.6K | $5.56M | $7.02M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$7.87M | -$10.97M | -$11.77M | -$15.73M | -$20.61M |
| Capital expenditure | - | -$70.4K | -$29.8K | -$5.2K | -$48.9K |
| Free cash flow | -$7.87M | -$11.04M | -$11.80M | -$15.74M | -$20.66M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LNAI | $1.13 | -0.9% | 23.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |